https://brandessenceresearch.com/ Logo

Over-the-Counter (OTC) Analgesics Market

Over-the-Counter (OTC) Analgesics Market Size, Share & Trends Analysis Report

Over-the-Counter (OTC) Analgesics Market Size, Share & Trends Analysis Report By Drugs (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates, Acetaminophen, Other Analgesics), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), Based On Region, And Segment Forecasts, 2022 - 2028

Published
Report ID : BMRC 17
Number of pages : 300
Published Date : Dec 2022
Category : Healthcare
Delivery Timeline : 48 hrs

Global Over-the-Counter (OTC) Analgesics Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing prevalence of diseases, rising adoption of self medication in pregnant women, AND growing availability of over-the-counter analgesics medicines are major factors anticipated to drive the growth of the Over-the-Counter (OTC) Analgesics Market.

Global Over-the-Counter (OTC) Analgesics Market is valued at USD 23.75 Billion in 2021 and expected to reach USD 32.54 Billion by 2028 with the CAGR of 4.6% over the forecast period.

Scope–

Over the counter analgesics can help decrease pain and lower a fever. For purchasing over the counter analgesics does not require any medical subscription. Acetaminophen, Aspirin, Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most common OTC pain treatments while non-aspirin pain relievers include acetaminophen (Tylenol). OTC analgesics help to relieve headaches, fever, and other typical aches and pains and also help to relieve swelling caused by arthritis or a sprain or strain of a muscle.

The Covid-19 pandemic has shown significant impact on the global over the counter analgesics market. The Covid-19 infection causes primarily fever and body pain and the over the counter (OTC) analgesics help to lower fever and minimize muscle aches from Covid-19, while also reducing some inflammation in body. Hence demand for cold and cough OTC drugs and focus on personalized health positively impacted the market. However, disturbance in the supply chain network during pandemic especially n the early phase has affected the market growth.

The global over-the-counter (OTC) analgesics market is segmented on the basis of type, drugs, distribution channel & country level. On the basis of drugs, the over the counter (OTC) the global market is classified into nonsteroidal anti-inflammatory drugs (NSAIDs), salicylates, acetaminophen      and other analgesics. On the basis of distribution channel, the global over the counter (OTC) analgesics market is classified into online pharmacies, retail pharmacies, hospital pharmacies and other distribution channels.

The regions covered in global over-the-counter (OTC) analgesics market report are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global over-the-counter (OTC) analgesics market is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.

Key Players-

Some of the key players for Global over-the-counter (OTC) analgesics market are -

  • Bayer AG
  • Pfizer Inc.
  • Cipla Inc
  • GlaxoSmithKline plc
  • Perrigo Co. Plc
  • Johnson & Johnson
  • Reckitt Benckiser Group plc
  • Piramal Enterprises Ltd.
  • AstraZeneca PLC
  • Sun Pharmaceutical Industries Ltd. 
  • others

Segmentation-

By Drugs:

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Salicylates
  • Acetaminophen
  • Other Analgesics

By Distribution Channel

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

By Regional & Country Level:

  • North America

    • U.S.
    • Canada
  • Europe

    • U.K.
    • France
    • Germany
    • Italy
  • Asia Pacific

    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America

    • Brazil
    • Mexico
  • Middle East and Africa

    • GCC
    • Africa
    • Rest of Middle East and Africa

Increasing Prevalence of Diseases, Rising Adoption of Self Medication in Pregnant Women and Growing Availability of Over-the-Counter Analgesics Medicines are Major Factors Driving the Market Growth

One of the major factors driving the growth of the global increasing prevalence of diseases. For instance; as per the Centers for Disease Control and Prevention (CDC), 20.4% of adults had chronic pain and 7.4% of adults had chronic pain in 2019. The over-the-counter analgesics relive pain and associated symptoms. In addition, rising adoption of self-medication is also supplementing the demand for over-the-counter (OTC) analgesics market. Self-medication with over-the-counter (OTC) medicines is becoming a progressively popular in pregnant woman’s due to basic medication knowledge in developing countries. For example; as per article published “self-medication among pregnant women” by NCBI (National Center for Biotechnology and Information) on September 6th, 2021, 297 pregnant women were studied A From April 2019 to February 2020 and it was observed that between the 297 women interviewed, 107 (36.0%) had practiced self-medication in 60 days.

Moreover, growing availability of over-the-counter analgesics is also fostering the market growth. The increasing number of generic products available in low price also driving the market growth of the global over the counter analgesics market. However, lack of knowledge especially among the patients in underdeveloped countries and rural areas may hamper the market growth. In spite of that, innovations, and technological advances in drug developments will provide more opportunities for the further growth of the global over-the-counter (OTC) analgesics market.

The North America Expected to Dominate Global over-the-counter (OTC) Analgesics Market

The North America is expected to dominate the global over-the-counter (OTC) analgesics market due to rising adoption of self-medication, increasing demand of over-the-counter (OTC) analgesics and growing incidences of chronic diseases in this region. Rising adoption of self-medication due to growing awareness is boosting the market growth. For instance; as per news published on March 12th, 2022; One in three Americans take over-the-counter pain medication every single day. In addition, increasing demand of over-the-counter medicines is also adding growth to the market. For instance; over-the-counter Diclofenac Sodium topical gel launched by Dr Reddy's Laboratories in September 2020 in U.S market. Moreover, growing incidences of chronic diseases and health awareness in North America is also acerating the market growth for the forecast period.

Asia Pacific is expected to be fastest growing market for the global over-the-counter (OTC) analgesics market due to the increasing adoption of self-medication, rising number of product launches and growing awareness amongst population in this region. The rising adoption of self-medication in developing countries such as India is boosting the market growth. For example; the prevalence of self-medication in India was 53.57 % in August 2020 as per “A Systematic Literature Review and Meta-Analysis” article published in Open Access Journal. In addition, rising number of product launches are also adding growth to the global over-the counter market in this region.

News-

New over The Counter Pain Killer Authorized in Spain

On July 18th, 2022; A new pain killer with a combination of paracetamol and ibuprofen, launched by the Spanish Medicines Agency. The new medicine will be sold in the form of tablets for oral intake. The developed Paracetamol/Ibuprofen Sandoz Care 500 MG/200 MG film-coated tablets can be sold without a prescription.

Hisamitsu America Announced Launch of Salonpas Arthritis Pain Relief Gel

On March 1st, 2021; The availability of the Salonpas Arthritis Pain Relief Gel, which features the most prescribed topical pain medicine clinically proven to relieve arthritis pain in major joints announced by Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., Inc., and the manufacturers of the Salonpas line of pain-relieving products. FDA approved this medicine for over-the-counter (OTC) use in 2020.

Report Analysis Details
Historical data 2018 - 2021
Forecast Period 2022 - 2028
Market Size in 2021: USD 23.75 Billion 
Base year considered 2021
Forecast Period CAGR %:

4.6%

Market Size Expected in 2028: USD 32.54 Billion
Tables, Charts & Figures: 175
Pages 200
Companies Bayer AG, Pfizer Inc., Cipla Inc, GlaxoSmithKline plc, Perrigo Co. Plc, Johnson & Johnson, Reckitt Benckiser Group plc, Piramal Enterprises Ltd., AstraZeneca PLC, Sun Pharmaceutical Industries Ltd. and others
Segments Covered By Drugs, By Distribution Channel
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
SUMMARY
VishalSawant
Vishal Sawant
Business Development
vishal@brandessenceresearch.com
+91 8830 254 358
Segmentation
Segments

By Drugs:

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Salicylates
  • Acetaminophen
  • Other Analgesics

By Distribution Channel

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels
Country
Regions and Country

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of MEA
Company
Key Players
  • Bayer AG
  • Pfizer Inc.
  • Cipla Inc
  • GlaxoSmithKline plc
  • Perrigo Co. Plc
  • Johnson & Johnson
  • Reckitt Benckiser Group plc
  • Piramal Enterprises Ltd.
  • AstraZeneca PLC
  • Sun Pharmaceutical Industries Ltd. 
  • others

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

BrandEssence® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®

PaymentModes